IRIS

Preparation of macrocyclic quinoline and naphthyridine peptides as HCV NS3 protease inhibitors useful in the treatment of hepatitis C infection / Rudd, ; Michael, T.; Mccauley, ; John, ; Liverton, ; Nigel, ; Grise-Bard, ; Christiane, ; Brouchu, ; Marie-Christine, ; Charron, ; Sylvie, ; Aulakh, ; Virender, ; Bachand, ; Benoit, ; Beaulieu, ; Patrick, ; Zaghdane, ; Helmi, ; Han, ; Yongxin, ; Ferrara, ; Marco, ; Harper, ; Steven, ; Summa, V; Chackalamannil, ; Samuel, ; Venkatraman, ; Srikanth, ; Shah, ; Unmesh, ; Velazquez, ; Francisco,. - (2012).

Preparation of macrocyclic quinoline and naphthyridine peptides as HCV NS3 protease inhibitors useful in the treatment of hepatitis C infection

Summa V;
2012
2012
Preparation of macrocyclic quinoline and naphthyridine peptides as HCV NS3 protease inhibitors useful in the treatment of hepatitis C infection / Rudd, ; Michael, T.; Mccauley, ; John, ; Liverton, ; Nigel, ; Grise-Bard, ; Christiane, ; Brouchu, ; Marie-Christine, ; Charron, ; Sylvie, ; Aulakh, ; Virender, ; Bachand, ; Benoit, ; Beaulieu, ; Patrick, ; Zaghdane, ; Helmi, ; Han, ; Yongxin, ; Ferrara, ; Marco, ; Harper, ; Steven, ; Summa, V; Chackalamannil, ; Samuel, ; Venkatraman, ; Srikanth, ; Shah, ; Unmesh, ; Velazquez, ; Francisco,. - (2012).
6.1 Brevetto
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/774294
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact